Skip to main content
Techno Medica Co., Ltd. logo

Techno Medica Co., Ltd. — Investor Relations & Filings

Ticker · 6678 ISIN · JP3545110003 T Manufacturing
Open in API
Filings indexed 67 across all filing types
Latest filing 2024-06-26 Governance Information
Country JP Japan
Listing T 6678

About Techno Medica Co., Ltd.

https://www.technomedica.co.jp/t01/Engl…

Techno Medica Co., Ltd. specializes in the research, development, manufacturing, and sale of in-vitro diagnostic (IVD) analyzers and automated pre-analytical systems for clinical laboratories. The company provides solutions that automate the workflow for blood and urine testing, covering processes from test registration and pre-analysis to patient identification and specimen transfer management. Its product portfolio includes next-generation IVD analyzers, such as electrolyte analyzers, and it is a leading manufacturer in the test tube market. The company focuses on delivering innovative products and services designed to enhance the efficiency, accuracy, and safety of laboratory diagnostics.

Recent filings

Filing Released Lang Actions
内部統制報告書－第37期(2023/04/01－2024/03/31)
Governance Information Classification · 100% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the cover page and throughout the text. It references the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項), which mandates the filing of an Internal Control Report. The content discusses the framework, scope, criteria, and conclusion regarding the effectiveness of internal controls over financial reporting as of the fiscal year-end (March 31, 2024). This directly corresponds to the requirements for an Audit Report / Information filing, specifically concerning internal controls, which aligns best with the 'AR' (Audit Report / Information) category among the provided options, as it is a formal report on internal control effectiveness, distinct from a full 10-K or a simple earnings release.
2024-06-26 Japanese
確認書
Audit Report / Information Classification · 98% confidence The document text contains the header "有価証券報告書（通常方式）" which translates to "Securities Report (Normal Method)". It also explicitly mentions the submission date, company name, and confirms the appropriateness of the contents of the '第37期（自2023年４月１日 至2024年３月31日）の有価証券報告書' (37th period Securities Report for the fiscal year ended March 31, 2024). A comprehensive Securities Report in Japan covering a full fiscal year is equivalent to the US 10-K filing. Although the document itself appears to be a confirmation statement ('確認書') related to the filing, the core subject matter is the Annual Report (Securities Report). Given the options, the closest and most relevant classification for the underlying document being confirmed is the Annual Report (10-K). If 'Confirmation of 10-K Filing' were an option, it might be better, but 10-K represents the annual filing itself. FY 2024
2024-06-26 Japanese
有価証券報告書－第37期(2023/04/01－2024/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, business descriptions, and management information for the fiscal year ending March 31, 2024. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. FY 2024
2024-06-26 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text contains the header "第３四半期報告書" (Third Quarter Report) and specifies the period covered: "第37期第３四半期（自2023年10月１日 至2023年12月31日）". It also includes a confirmation statement regarding the appropriateness of the quarterly report's contents, filed with the Kanto Local Finance Bureau. This structure strongly indicates a comprehensive financial report for an interim period shorter than a year, which corresponds to the definition of an Interim / Quarterly Report (IR). The document length is very short (567 chars), but the content is the substance of the report confirmation itself, not just an announcement of publication, making IR more appropriate than RPA/RNS, although it is a confirmation document related to the filing.
2024-02-13 Japanese
四半期報告書－第37期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第３四半期報告書) for Techno Medica Co., Ltd. for the period ending December 31, 2023. It contains detailed financial statements (balance sheet, income statement), notes to financial statements, and management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the Second Quarter Report (Interim Report). While it references the quarterly report, the document itself is a formal regulatory filing confirming the validity of the financial statements for the period ending September 30, 2023. Since it is a specific regulatory filing required by Japanese law for financial reporting, and does not fit into the 'Interim Report' (IR) category itself (which would be the full report), it is best classified as a Regulatory Filing (RNS).
2023-11-10 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.